Dr. Robert Moskovitch is the Head of the Complex Data Analytics Lab, at the department of Software and Information Systems Engineering at Ben Gurion University, after he did his post doc fellowship at Columbia University. He is a member of the advisory board of the new center for bioinformatics and analytics at the Columbia University Medical Center, and a member of BGU Zlotowsky Center for Neuroscience, and the Center for CyberSecurity. Prior to that, he headed several Research and Development projects in Information Security at Deutsche Telekom Innovation Laboratories at BGU. He has served on several journal editorial boards, as well as on program committees of several conferences, such as ACM KDD and IEEE ICHI and workshops in Information Security and Biomedical Informatics. He published more than seventy peer reviewed papers in leading journals and conferences, such as IEEE ICDM, Data Mining and Knowledge Discovery, KAIS, JAMIA, JBI and more, several of which had won best-paper awards. His lab focuses mainly on the development of Temporal Data Analytics methods, and its use for outcomes prediction in the biomedical domain, but not only.

Levi Shapiro is the Founder of mHealth Israel, a non profit supporting Israel’s connected health
and medtech startup community, with 4,500 members. The organization hosts Meetups, four
global roadshows, a comprehensive database and the mHealth Israel conference, the largest
showcase for digital health innovation. Levi is an Adjunct Professor at IDC Herzliya, in the
Adelson School of Entrepreneurship. He writes about healthcare and technology in the Jerusalem
Post, holds Board positions at multiple health tech startups, and advises several prominent multi-
national healthcare companies.
During a career spanning more than two decades, including seven years in Beijing and Tokyo,
Mr. Shapiro launched new business units (IBM), new products and services (Toyota) and a
variety of technology startups (Two Minute Television, Snack Mobile, etc). He is an investor and
Board Member in several Israeli connected health startups and formerly a General Partner in the
Israel-based venture capital firm, Veritas. Mr. Shapiro holds degrees from Tulane (BA), Cornell
(Asian Studies) and MIT (MBA).

Big Data platform manager at the Israeli Ministry of Health. Headed building of the platform version 1.0 and currently expanding data sharing and facilitating new research. Aline also helps consolidating efforts regarding national aspects of this endeavor such as regulation, privacy best practices, innovation promotion among other things. 

Since 1995 Aline served in various IT positions including designing, consulting, establishing and managing large-scale business intelligence initiatives for major firms in Israel and abroad. Between 2010 and 2014 she directed the Business Intelligence and Data Infrastructure Department of the Phoenix Insurance Co. Main expertise are data modeling, data infrastructure and commercial risk management. Ms. Attias holds a BSc. degree in Information Systems Engineering, received from the Technion and MA in Management from Boston University.

Dr. Andrey Broisman is Director of Applied Science and Engineering at the Ministry of Science and Technology. He specializes in medical devices and has years of experience in product design and development. He has been an integral member of many teams consisting of design engineers, manufacturing engineers, and consulting clinicians with the over-arching goal to develop medical devices to improve patient care. Working within these teams, he has established end-user and device requirements, designed devices via CAD software, programmed software and control systems, and contributed to both the design verification and device validation processes throughout the development cycle

Dr. Dulchavsky is currently a professor of surgery, molecular biology and genetics at Wayne
State University School of Medicine. He serves as the Roy D. McClure Chairman of Surgery and
the Surgeon in Chief at Henry Ford Health System in Detroit, Michigan and is the founder and
CEO of the Innovation Institute at Henry Ford. He is a principal investigator for NASA and for
the National Space Biomedical Research Institute working to enhance medical care capabilities
on the International Space Station and for exploration class spaceflight; these techniques have
been successfully transitioned to Earth to improve care in under-resourced regions.

Joseph Fernando is a Principal Architect within ARM's IoT Vertical Markets business group with over twenty-five years of hands on, end-to-end software architecture, development, product/program management and leadership experience.   He is currently working on healthcare IoT initiatives, standardization efforts and Robotics.  Previously, as the Head Innovator and Technical Advisor to T-Mobile's IoT & M2M business group, he has successfully managed help align company’s IoT/M2M technology investments, R&D and strategic partner engagements to yield long-term growth opportunities and support organization with key customer segments.  Prior to T-Mobile, Joseph helped Vertafore architect and release two major revisions of their enterprise-class n-tier web applications and transform to cloud services.  During his eighteen-year tenure at Microsoft, Joseph drove initiatives to enhance software architecture, design, development and has helped the company successfully ship over nineteen software products - ranging from robotic/real time systems to enterprise/cloud solutions to productivity/developer tools & platforms to media solutions, to embedded systems. He holds several seven patents in the areas of computation and extensible platforms. He earned his undergraduate degree from Knox College with a double major in Computer Science (Honors) and Physics; and a Master of Science in Electrical Engineering from Oakland University. His graduate research was in the area of adaptive controls.

Dr. Granowitz joined Amarin in January 2016 with extensive experience managing a multi-national medical affairs organization for a portfolio of leading cardiovascular products. Prior to joining Amarin, Dr. Granowitz was senior vice president and head of global medical affairs, global human health at Merck, where he developed and implemented an entirely new global medical affairs organization following Merck’s merger with Schering-Plough. In this capacity, among his numerous achievements, he provided critical medical affairs support in the run-up to and read-out of Merck’s cardiovascular outcomes study, IMPROVE-IT. From 2003 to 2008, he was group vice president, head of global medical affairs for Schering-Plough. 
Dr. Granowitz has been elected to serve on the Board of Directors of the New York City American Heart Association starting in June, 2017. Dr. Granowitz currently serves as a volunteer on the boards of directors of several organizations including the Columbia College of Physicians and Surgeons, the Rabbinical College of America and the American Associates of Ben Gurion University.

Tzvika Hartman has been with Google Tel-Aviv for more than 10 years, working on various projects such as Google Search, Google Trends, Network Optimization, Cultural Institute and more. He is now leading an engineering team, whose mission is to develop technologies that help facilitate advanced research on healthcare data.

Tzvika holds a computer science PhD from the Weizmann Institute. His thesis is on combinatorial algorithms for molecular biology.

Mark is an allergist/immunologist, practicing in Vermont since 1993. He obtained his B.Sc and M.Sc degrees from McGill University in Montreal, Canada and graduated with Honors from the Medical School of the Universite de Liege, Belgium.  Internal Medicine Residency at Yale University Medical School/Bridgeport Hospital in Bridgeport CT. Fellow in Allergy and Clinical Immunology at SUNY at Stony Brook. Partner at Timberlane Allergy and Asthma Associates in South Burlington VT and a member of the  Health Informatics, Technology and Education Committee of the American Academy of Asthma Allergy and Immunology. Creator of AllerPassMD, website listing and rating  of hotels for allergic and asthmatic travelers. 

 Dr. Lazarovich interest is the use of AI in lifestyle modification as part of management and prevention of chronic disease.  Participant at Beyond the Quantified Self Workshop, 2015 ACM Conference on Computer-Supported Cooperative Work and Social Computing in Vancouver, Canada.    Presenter, including Dec 2016 at the World Allergy International Scientific Conference in Jerusalem.

Adv. Roy Melzer is Head of Software and Information System Department at Ehrlich & Fenster and manages the activity of the department, which focuses on drafting and prosecuting patent applications for various computer based inventions for International and Israeli companies and entrepreneurs.

Roy specializes in cases involving complex technical subject matter and legal issues, especially those relating to computer implemented inventions. Adv. Roy Melzer manages drafting and prosecuting priority patent applications for clients such as IBM, Samsung, CyberArk, Top Image Systems, Medical Sensible and many others.

Head, Clinical Research Center, Head, Research Authority, Soroka University Medical Center, Israel

Prof. Victor Novack MD, PhD is the founding director of Soroka-BGU Medical Research Institute and Head of the Research Authority at Soroka University Medical Center, the second largest hospital in Israel and a single provider of the tertiary care to a population of 1.2 mln. Prior to his current position, Prof. Novack served as a Medical Director at Harvard Clinical Research Institute, Boston USA. His epidemiology training allows for the bridging a gap between the clinical questions and statistical apparatus. He has designed and contributed to the design of more than 50 feasibility and pivotal trials for FDA approval. Prof. Novack is Professor of Medicine at Faculty of Health Sciences at Ben-Gurion University, attending in the Division of Medicine at Soroka University Medical Center and Senior Scientist at Beth Israel Deaconess Medical Center, Harvard Medical School. He is an Associate and Statistical Editor of the European Journal of Internal Medicine. He has more than 170 scientific publications in peer reviewed journals. His scientific interests lays at the application of the evolving statistical and epidemiological methodology to the clinically driven research questions.

Dr Satish Prasad Rath, is currently heading the healthcare research at Conduent Labs . Conduent is the new arm formed out of Xerox corporation responsible for the majority services revenue in areas like healthcare , transport and customer care. In past he has led labs at Wipro (CTO Office) , Intel ( health systems research, colocated at CMU, University of Washington , Berkely . Intel Capital) , Philips. His areas of research are point of care systems, health systems, healthcare economics, usability in health design, wearable , mPersuasion and clinical decision support system. He has various publication and patents and products . Few notable firsts are first multi- sensory wearable, continuous authentication or physiological key,  design of healthcare systems at BOP, innovation in PPP mode , corporate venture, first remote pregnancy monitoring etc. He is known for running corporate labs as start-ups and advises incubators and accelerators on “innovation portfolio management”. He is board member/mentor at DERBI foundation, BIRAC incubators, NUMA accelerator, Revvx Accelerator etc.

Prof. Varda Shalev, MD MPH, is the director of the institute of research and innovation Maccabitech (Big-data and Epidemiology research), and an active primary care physician in Maccabi Health Care Services. With an MD degree from Ben Gurion University Medical School, she completed her residency in family medicine and earned an MPA in Public Health Administration at Clark University. After a two year fellowship in medical informatics at the Johns Hopkins University Hospital, Prof. Shalev established the Department of Medical Informatics at Maccabi and was responsible for planning and developing its computerized medical systems. She has pioneered the development of multiple disease registries to support chronic disease management. She served as the director of primary care division in Maccabi. Shalev's research interests are in epidemiology, medical informatics and predictive analytics in community healthcare. She is a member of the European Health Telematics Association and the American Medical Informatics Association. Prof. Shalev is an Associate Professor at the Tel Aviv University School of Public Health, the teaches Big-data and medical informatics in Tel Aviv university. She has authored or coauthored over 031 publications in peer-reviewed journals

Jeremy joined Novartis in 2015 as VP, Head of Digital Business Development & Licensing supporting Novartis’ Digital Medicines program. In 2016, Jeremy also served as Global Head of Digital Development, Novartis Pharma. 

Jeremy is a serial software entrepreneur with more than 17 years of experience founding and managing healthcare and technology companies. Prior to Novartis, Jeremy was Managing Director at MPM Capital where he led the firm's digital-health investment strategy. At MPM, Jeremy founded two companies, CentrosHealth (acquired by Clinical Ink) and TriNetX. In 2011, Jeremy co-founded GrapeVine, a software company that optimizes how organizations connect with their target communities. From 2007-2011, Jeremy was COO and VP, Strategy & Corporate Development for North Plains Systems, where he lead the company's growth and eventual sale to Accel-KKR. In 2000, he co-founded an open-source operating system company, Wasabi Systems.

NICHOLAS P. TATONETTI is Herbert Irving Assistant Professor of Biomedical Informatics at Columbia University with interdisciplinary appointments in the Department of Systems Biology and the Department of Medicine. He received a Ph.D. in Biomedical Informatics from Stanford University in 2012, and dual B.S. degrees from Arizona State University in computational mathematics and molecular biosciences/biotechnology in 2008. Dr. Tatonetti's research is focused on advancing our understanding of drug effects and drug combinations through the integration of observational clinical data and high-throughput molecular data. A recognized expert in adverse drug effects, Dr. Tatonetti is responsible for discovering previously unexpected drug interactions causing heart arrhythmias and glucose dysregulation.

Dr. Tatonetti is an Irving Scholar, a Kavli Fellow, the recipient of New Investigator Awards from the American Medical Informatics Association (2016) and the PhRMA Foundation (2014), and has been awarded over $4 million in research funding. His work has received multiple awards from the informatics in 2010, 2011, 2012, and 2015. Dr. Tatonetti's career has been profiled by Science Magazine (2011), Genome Web (2012), and AMIA (2016). He is author on over 90 peer-reviewed scientific publics, inventor on two patents, and his work as been covered by the popular and scientific press, including The New York Times, The Chicago Tribune, The Boston Globe, and others.

Elad Yom-Tov is a Principal Researcher at Microsoft Research and a Visiting Assistant Professor at the Faculty of Industrial Engineering and Management, Technion. Before joining Microsoft he was with Yahoo Research, IBM Research, and Rafael. Dr. Yom-Tov studied at Tel-Aviv University and the Technion. He has published four books, over 100 papers (of which 4 were awarded prizes), and was granted more than 20 patents. His primary research interests are in using Machine Learning and  Information Retrieval to improve health. His latest book is “Crowdsourced Health: How What You Do on the Internet Will Improve Medicine” (MIT Press, 2016).